• About Galen

    About Galen

Committed to innovation, quality and customer focus to advance human health

Galen is a global pharmaceutical company selling medicines worldwide in the areas of pain management, dermatology and gastroenterology, and partners with like-minded companies to accomplish this.

Established in 1968, with headquarters in Craigavon, Northern Ireland, we work in partnership with healthcare professionals and patients to advance human health.

We actively seek new markets and new opportunities, toward fulfilling our vision of creating a truly international pharmaceutical company from our base in Northern Ireland.

See below for more on our business, our background and our values.


  • Company Overview

    By combining innovation in product development with competitive pricing, Galen works in partnership with healthcare professionals and patients to create real, long-term value, a major factor in the company’s success to date.

    Galen is a privately owned pharmaceutical company established in 1968, with headquarters in Craigavon, Northern Ireland.

    Our expertise lies in

    • sales, marketing and launch excellence
    • market access
    • regulatory affairs, pharmacovigilance and medical affairs
    • supply chain and logistics.

    We market pharmaceuticals across the UK, Europe, the USA and the Nordics.

    Through organic growth and acquisitions, Galen has established product sales in 23 countries.

    With commercial operations based in the UK, Ireland, USA and the Nordics, Galen is also a lead member of Rx-Alliance, an international network of partners. 

    Galen is proud to be one of the Almac Group family of world-class companies in the pharmaceutical and biotech sectors.  The Group is wholly owned by the McClay Foundation, whose overarching aim is to make a meaningful improvement and advancement in human health.

  • Galen's story

    Galen was founded in Craigavon, Northern Ireland in 1968 by the late Sir Allen McClay (d. 2010), the revered philanthropist and entrepreneur.

    Sir Allen invested his wealth in research and innovation, to ensure the latest advances in healthcare would be available to all, and to foster employment opportunities locally. In 1997, Galen became Northern Ireland’s first £1 billion company.

    • In 2002, Sir Allen formed what is now known as the Almac Group from his personal wealth, whilst maintaining his controlling share of Galen.
    • He later established the McClay Foundation as a charitable institution, donating more than £20 million to enhance the research capabilities at Queen’s University Belfast.
    • Galen is proud to be one of the Almac Group family of world-class companies in the pharmaceutical and biotech sectors. The Group is wholly owned by the McClay Foundation, whose overarching aim is to make a meaningful improvement and advancement in human health.

    We champion the values upon which Galen was built, and remain passionate about Sir Allen’s mission to improve and optimise human health, and to achieve a meaningful impact on patients' lives.

     Timeline


50

Years Experience

23

Successfully Launched Products

9

Areas of Therapy Expertise

Our Locations

Global and EU Headquarters

  • Galen Limited
  • 20 Seagoe Industrial Estate
  • Craigavon BT63 5QD
  • United Kindom
  •  
  • +44(0)28 3833 2200
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

US Headquarters

  • Galen US Inc.
  • 2661 Audubon Road
  • Audubon
  • PA 19403
  • United States of America
  • +1(215) 660 8500
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Operations

Dundalk, IE

Galen Pharma Ireland Limited
Finnabair Industrial Estate
Dundalk, Co. Louth
Ireland

Telephone: +353 42 932 0718

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Operations

Audubon, PA

Galen US Inc.
2661, Audubon Road,
Audubon PA 19403, 
United States of America

Telephone:  +1(215) 660 8500

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Nordics

Gothenburg, Sweeden

POA Pharma Scandinavia AB,

Ebbe Lieberathsgatan 21, Box 24026,

400 22 Gothenburg Sweden

Would you like to discuss how Galen can help you?

If you would like to explore how Galen’s expertise could add value to your product, or for an initial discussion about partnering with us, please contact our team.